Abstract
Although the therapeutic benefit of oral antimalarials in various types of sarcoidosis is well described, their reported use specifically in subcutaneous sarcoidosis (Darier-Roussy type sarcoidosis) is limited. We describe the cases of two patients with subcutaneous sarcoidosis treated with hydroxychloroquine, suggesting that it may represent an alternative first-line treatment for patients in whom steroid-sparing therapy is desired.
Original language | English |
---|---|
Journal | Dermatology Online Journal |
Volume | 20 |
Issue number | 1 |
State | Published - 2014 |
Externally published | Yes |
Keywords
- Antimalarials
- Darier-Roussy
- Hydroxychloroquine
- Sarcoidosis
- Sarcoidosis/classification
- Sarcoidosis/drug therapy
- Sarcoidosis/pathology
- Sarcoidosis/therapy
- Subcutaneous sarcoidosis